跳至主要内容
临床试验/JPRN-UMIN000012196
JPRN-UMIN000012196已完成未知

The Study on HElicobacter Pylori eradication in patients with HEPatic complications - HepHep Study

Osaka City University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2019年3月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with history of hypersensitivity to lansoprazole, amoxicillin, and clarithromycin. 2. Patients being treated with atazanavir, rilpivirine, pimozide, preparation containing ergotamine and tadalafil. 3. Patients with liver or kidney diseases being treated with colchicine. 4. Patients with infectious mononucleosis. 5. Patients with severe renal impairment. 6. Woman during the first three months of pregnancy. 7. Patients whom the principal and/or sub-investigators judged inadequate.

研究者

发起方
Osaka City University Graduate School of Medicine

相似试验